Get In Touch

Global Cartilage Degeneration Market: Snapshot

Cartilage is a soft, rubbery material found in joints. The function of the cartilage is to avoid friction between bones; thus, it works as a shock absorber in the joint. Injury to the cartilage restricts the regular movement of the joint and can cause severe pain. If left untreated or if the injury is serious, it may require joint replacement surgery. Impairment to articular cartilage generally occurs after accidental injury or trauma to joints such as knees or hips. Cartilage degeneration may occur due to diseases such as arthritis and osteoarthritis as well.

Factors such as the increase in the global geriatric population, increase in the number of sports injuries, and rise in the obese population are key factors which drive the growth of cartilage degeneration market. However, increase in the cost of surgical treatment and devices and lack of reimbursement policies in emerging countries are some of the factors which may hinder the market growth.

According to Transparency Market Research, the global cartilage degeneration market was valued at US$9.5 bn in 2017 and is likely to reach US$14.7 bn by 2025. The market is expected to exhibit a strong 5.6% CAGR in the forecast period.

cartilage degeneration market

Joint Replacements Likely to Lead Demand from Cartilage Degeneration Market

The global cartilage degeneration market is classified by procedure type, application, and treatment delivery channel. By procedure type the market is categorized into joint replacements, chondroplasty, osteochondral transplants, micro-fracture, meniscus transplants, cell based cartilage resurfacing, autologous chondrocyte implantation (ACI), and others. By application, the cartilage degeneration market is divided into knees, hips, and others. By treatment delivery channel the market is classified into hospitals, academic and research institutes, specialty clinics, ambulatory surgical centers, and others.

By procedure type, joint replacements accounted for the largest share of the market in 2016. Following joint replacements, the chondroplasty segment accounted for a major share in the cartilage degeneration market in 2016. The key elements responsible for the growth of this market are the easy accessibility of the procedure in hospitals and diagnostic centers. Chondroplasty also takes less time for recovery in comparison with other traditional methods of surgery. Autologous chondrocyte implantation (ACI) is a comparatively new technology used for the treatment of isolated full-thickness articular cartilage imperfections of the knee.

By application, the knee surgery or repair market is anticipated to dominate the cartilage degeneration market in the near future. Knees are the largest joints in a human body. According to a report from the Centers for Disease Control and Prevention, in 2014, about 13% of women and 10% of men aged 60 years and older have indicative knee osteoarthritis symptoms. The growing prevalence of the disease is thus likely to drive the demand for knee surgeries in the coming years.

North America to Dominate Cartilage Degeneration Market due to Widespread Healthcare Infrastructure

Geographically, the global cartilage denegation market has been differentiated into the following regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the global market till 2025 due to the widespread access to satisfactory reimbursement policies due to the provision of the Affordable Care Act and increasing incidence of joint injuries. The North America market for cartilage degeneration was valued at US$3.9 bn in 2017 and is expected to rise to US$6.1 bn by 2025 at a stable CAGR of 5.7%.

Asia Pacific is projected to be a rapidly growing market for cartilage degeneration procedures during the forecast period due to robust economic growth in countries such as Australia, the Philippines, China, Singapore, India, and others. Furthermore, substantial growth in the geriatric population is anticipated to encourage the growth of the global cartilage degeneration market in the region. The Asia Pacific cartilage degeneration market is likely to exhibit a robust 6.1% CAGR between 2017 and 2025, rising from a valuation of US$1.9 bn to US$3.2 bn therein.

The global cartilage degeneration market includes key companies such as DePuy Synthes, Zimmer Biomet, Stryker Corporation, Smith & Nephew plc, and B. Braun Melsungen AG, among others.

Global Cartilage Degeneration Market: Overview

This report on cartilage degeneration studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global cartilage degeneration market with respect to the leading market segments based on major products, key applications, end-users, and geographies.

Global Cartilage Degeneration Market: Scope and Research Methodology

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2016 to 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all segments, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global cartilage degeneration market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/materials/end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Cartilage Degeneration Market: Segmentation

The global cartilage degeneration market is classified in to procedure type, application, and treatment delivery channels. By procedure type the market is categorized as Joint Replacements, Chondroplasty, Osteochondral Transplants, Micro-Fracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation (ACI), Others. By application the market is divided in to knee, hips & others. By treatment delivery channels the market is classified as Hospitals, Academic & Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others.

Geographically, the cartilage degeneration market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market has been further categorized into major product, material, and end-user segments considered within the scope of the study. Key country (U.S., Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2016 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Global Cartilage Degeneration Market: Competitive Dynamics

The report also profiles key players operating in the cartilage degeneration market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include B. Braun Melsungen AG, DePuy Synthes, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global cartilage degeneration market is segmented into the following categories:

by Procedure Type

  • Joint Replacements
  • Chondroplasty
  • Osteochondral Transplants
  • Microfracture
  • Meniscus Transplants
  • Cell based Cartilage Resurfacing
  • Autologus Chondrocyte Implantation
  • Others

by Application

  • Knee
  • Hip
  • Others

by Treatment Delivery Channels

  • Hospitals
  • Academic & Research Institutes
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of MEA

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used 
2.2 Research Methodology

Section 3 Executive Summary
3.1 Market Introduction 
3.2 Global Cartilage Degeneration Market Size ($ Mn) and Distribution, by Geography, 2017 and 2025
3.3 Global Cartilage Degeneration Market Size ($ Mn), by Procedure, 2017 and 2025
3.4 Global Cartilage Degeneration Market Size ($ Mn), by Application, 2017 and 2025
3.5 Global Cartilage Degeneration Market Size ($ Mn), by Treatment Delivery Channels, 2017 and 2025

Section 4 Market Overview
4.1 Overview
4.2 Recent Developments 
4.3 Mergers & Acquisitions Update
4.4 Global Cartilage Degeneration Market Size (US$ Mn) Forecast, 2015–2025

Section 5 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunities
4.3 Global Cartilage Degeneration Market: Porter's Analysis 
5.4 Cartilage Degeneration Market- Value Chain Analysis
5.5 Pipeline Analysis of Osteoarthritis Drugs 
5.6 Randomized Clinical Trials (RCTs) for Cartilage Repair
5.7 Comparison between Percentage Distribution of Population Aged 65 and Over, by Region
5.8 Obesity Rates (%) of Total Adult Population in 2015

Section 6 Global Cartilage Degeneration Market Analysis, by Procedure
6.1 Key Findings
6.2 Introduction
6.3 Global Cartilage Degeneration Market Value Share Analysis, by Procedure Type
6.4 Global Cartilage Degeneration Market Attractiveness, by Procedure Type
6.5 Global Cartilage Degeneration Market Forecast, by Procedure Type
6.6 Global Cartilage Degeneration Market Analysis, by Procedure Type
6.7 Key Trends

Section 7 Global Cartilage Degeneration Market Analysis, by Application
7.1 Key Findings
7.2 Introduction
7.3 Global Cartilage Degeneration Market Value Share Analysis, by Application 
7.4 Global Cartilage Degeneration Market Attractiveness, by Application
7.5 Global Cartilage Degeneration Market Forecast, by Application
7.6 Global Cartilage Degeneration Market Analysis, by Application
7.7 Key Trends

Section 8 Global Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
8.1 Key Findings
8.2 Introduction
8.3 Global Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel
8.4 Global Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel
8.5 Global Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
8.6 Global Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
8.7 Key Trends

Section 9 Global Cartilage Degeneration Market Analysis, by Region
9.1 Global Cartilage Degeneration Market Snapshot, by Country
9.2 Global Cartilage Degeneration Market Value Share Analysis, by Region
9.3 Cartilage Degeneration Market Forecast, by Region
9.4 Cartilage Degeneration Market Attractiveness Analysis, by Region
9.5 Key Findings

Section 10 North America Cartilage Degeneration Market Analysis
10.1 North America Cartilage Degeneration Market Overview
10.2 Market Value Share Analysis, by Country
10.3 North America Market Value Share Analysis, by Country
10.4 North America Cartilage Degeneration Market Forecast, by Country
10.5 North America Cartilage Degeneration Market Analysis, by Procedure
10.6 North America Cartilage Degeneration Market Attractiveness, by Procedure
10.7 North America Cartilage Degeneration Market Forecast, by Procedure
10.8 North America Cartilage Degeneration Market Analysis, by Application
10.9 North America Cartilage Degeneration Market Forecast, by Application
10.10 North America Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
10.11 North America Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
10.12 Market Trends

Section 11 Europe Cartilage Degeneration Market Analysis
11.1 Europe Cartilage Degeneration Market Overview
11.2 Market Value Share Analysis, by Country
11.3 Europe Market Value Share Analysis, by Country
11.4 Europe Cartilage Degeneration Market Forecast, by Country
11.5 Europe Cartilage Degeneration Market Analysis, by Procedure
11.6 Europe Cartilage Degeneration Market Attractiveness, by Procedure
11.7 Europe Cartilage Degeneration Market Forecast, by Procedure
11.8 Europe Cartilage Degeneration Market Analysis, by Application
11.9 Europe Cartilage Degeneration Market Forecast, by Application
11.10 Europe Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
11.11 Europe Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
11.12 Market Trends

Section 12 Asia Pacific Cartilage Degeneration Market Analysis
12.1 Asia Pacific Cartilage Degeneration Market Overview
12.2 Market Value Share Analysis, by Country
12.3 Asia Pacific Market Value Share Analysis, by Country
12.4 Asia Pacific Cartilage Degeneration Market Forecast, by Country
12.5 Asia Pacific Cartilage Degeneration Market Analysis, by Procedure
12.6 Asia Pacific Cartilage Degeneration Market Attractiveness, by Procedure
12.7 Asia Pacific Cartilage Degeneration Market Forecast, by Procedure
12.8 Asia Pacific Cartilage Degeneration Market Analysis, by Application
12.9 Asia Pacific Cartilage Degeneration Market Forecast, by Application
12.10 Asia Pacific Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
12.11 Asia Pacific Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
12.12 Market Trends

Section 13 Latin America Cartilage Degeneration Market Analysis
13.1 Latin America Cartilage Degeneration Market Overview
13.2 Market Value Share Analysis, by Country
13.3 Latin America Market Value Share Analysis, by Country
13.4 Latin America Cartilage Degeneration Market Forecast, by Country
13.5 Latin America Cartilage Degeneration Market Analysis, by Procedure
13.6 Latin America Cartilage Degeneration Market Attractiveness, by Procedure
13.7 Latin America Cartilage Degeneration Market Forecast, by Procedure
13.8 Latin America Cartilage Degeneration Market Analysis, by Application
13.9 Latin America Cartilage Degeneration Market Forecast, by Application
13.10 Latin America Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
13.11 Latin America Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
13.12 Market Trends

Section 14 Middle East & Africa Cartilage Degeneration Market Analysis
14.1 Middle East & Africa Cartilage Degeneration Market Overview
14.2 Market Value Share Analysis, by Country
14.3 Middle East & Africa Market Value Share Analysis, by Country
14.4 Middle East & Africa Cartilage Degeneration Market Forecast, by Country
14.5 Middle East & Africa Cartilage Degeneration Market Analysis, by Procedure
14.6 Middle East & Africa Cartilage Degeneration Market Attractiveness, by Procedure
14.7 Middle East & Africa Cartilage Degeneration Market Forecast, by Procedure
14.8 Middle East & Africa Cartilage Degeneration Market Analysis, by Application
14.9 Middle East & Africa Cartilage Degeneration Market Forecast, by Application
14.10 Middle East & Africa Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
14.11 Middle East & Africa Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
14.12 Market Trends

Section 15 Competition Landscape
15.1 Competition Matrix 
15.2 Cartilage Degeneration Market Share Analysis

Section 16 Company Profiles
16.1 Zimmer Biomet Holdings, Inc.
       16.1.1  Company Overview
       16.1.2  Business Overview
       16.1.3  Financial Overview
       16.1.4  SWOT Analysis
       16.1.5  Strategic Overview
16.2 Stryker Corporation
       16.2.1  Company Overview
       16.2.2  Business Overview
       16.2.3  Financial Overview
       16.2.4  SWOT Analysis
       16.2.5  Strategic Overview
16.3 Smith & Nephew plc 
       16.3.1  Company Overview
       16.3.2  Business Overview
       16.3.3  Financial Overview
       16.3.4  SWOT Analysis
       16.3.5  Strategic Overview
16.4 B. Braun Melsungen AG 
       16.4.1  Company Overview
       16.4.2  Business Overview
       16.4.3  Financial Overview
       16.4.4  SWOT Analysis
       16.4.5  Strategic Overview
16.5 Medtronic plc 
       16.5.1  Company Overview
       16.5.2  Business Overview
       16.5.3  Financial Overview
       16.5.4  SWOT Analysis
       16.5.5  Strategic Overview
16.6 Johnson & Johnson (DePuy Synthes) 
       16.6.1  Company Overview
       16.6.2  Business Overview
       16.6.3  Financial Overview
       16.6.4  SWOT Analysis
       16.6.5  Strategic Overview
16.7 Osiris Therapeutics, Inc. 
       16.7.1  Company Overview
       16.7.2  Business Overview
       16.7.3  Financial Overview
       16.7.4  SWOT Analysis
       16.7.5  Strategic Overview
16.8 Vericel Corporation 
       16.8.1  Company Overview
       16.8.2  Business Overview
       16.8.3  Financial Overview
       16.8.4  SWOT Analysis
       16.8.5  Strategic Overview
16.9 Anika Therapeutics, Inc. 
       16.9.1  Company Overview
       16.9.2  Business Overview
       16.9.3  Financial Overview
       16.9.4  SWOT Analysis
       16.9.5  Strategic Overview
16.10 MEDIPOST Co., Ltd. 
       16.10.1  Company Overview
       16.10.2  Business Overview
       16.10.3  Financial Overview
       16.10.4  SWOT Analysis
       16.10.5  Strategic Overview
16.11 CONMED Corporation 
       16.11.1  Company Overview
       16.11.2  Business Overview
       16.11.3  Financial Overview
       16.11.4  SWOT Analysis
       16.11.5  Strategic Overview
16.12 Arthrex, Inc.
       16.12.1  Company Overview
       16.12.2  Business Overview
       16.12.3  Financial Overview
       16.12.4  SWOT Analysis
       16.12.5  Strategic Overview

List of Tables

Table 01: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2015–2025
Table 02: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 04: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 07: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 08: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 09: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 11: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 13: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 15: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 16: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channels, 2015–2025
Table 17: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 19: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 21: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 23: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 25: Business Overview Zimmer Biomet Holdings, Inc.
Table 26: Business Overview Stryker Corporation
Table 27: Business Overview Smith & Nephew plc
Table 28: Business Overview B. Braun Melsungen AG
Table 29: Business Overview Medtronic plc
Table 30: Business Overview Johnson & Johnson (DePuy Synthes)
Table 31: Business Overview Osiris Therapeutics, Inc.
Table 32: Business Overview Vericel Corporation
Table 33: Business Overview Anika Therapeutics, Inc.
Table 34: Business Overview MEDIPOST Co., Ltd.
Table 35: Business Overview CONMED Corporation
Table 36: Business Overview Arthrex, Inc.

List of Figures

Figure 01: Global Cartilage Degeneration Market Size ($ Mn) and Distribution, by Geography, 2017 and 2025
Figure 02: Global Cartilage Degeneration Market Size ($ Mn), by Procedure, 2017 and 2025
Figure 03: Global Cartilage Degeneration Market Size ($ Mn), by Application, 2017 and 2025
Figure 04: Global Cartilage Degeneration Market Size ($ Mn), By Treatment Delivery Channels, 2017 and 2025
Figure 05: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, 2015–2025
Figure 06: Global Cartilage Degeneration Market Value Share, by Procedure Type, 2017 and 2025
Figure 07: Global Cartilage Degeneration Market Attractiveness, by Procedure Type, 2017–2025
Figure 08: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Joint Replacement, 2015–2025
Figure 09: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chondroplasty, 2015–2025
Figure 10: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Osteochondral Transplants, 2015–2025
Figure 11: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microfracture, 2015–2025
Figure 12: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Meniscus Transplant, 2015–2025
Figure 13: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell-based Cartilage Resurfacing, 2015–2025
Figure 14: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autologous Chondrocyte Implantation (ACI), 2015–2025
Figure 15: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 16: Global Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 17: Global Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 18: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knee, 2015–2025
Figure 19: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hip, 2015–2025
Figure 20: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 21: Global Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 22: Global Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 23: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 24: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics & Research Institutes, 2015–2025
Figure 25: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2015–2025
Figure 26: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2015–2025
Figure 27: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 28: Global Cartilage Degeneration Market Value Share, by Region, 2017 and 2025
Figure 29: Global Cartilage Degeneration Market Attractiveness, by Region, 2017–2025
Figure 30: North America Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 31: North America Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 32: North America Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 33: North America Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 34: North America Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 35: North America Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 36: North America Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 37: North America Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 38: North America Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 39: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 40: Europe Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 41: Europe Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 42: Europe Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 43: Europe Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 44: Europe Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 45: Europe Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 46: Europe Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 47: Europe Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 48: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 49: Asia Pacific Cartilage Degeneration Market Attractiveness, by Country, 2017–2025        
Figure 50: Asia Pacific Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 51: Asia Pacific Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 52: Asia Pacific Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 53: Asia Pacific Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 54: Asia Pacific Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 55: Asia Pacific Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 56: Asia Pacific Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 57: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 58: Latin America Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 59: Latin America Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 60: Latin America Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 61: Latin America Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 62: Latin America Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 63: Latin America Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 64: Latin America Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 65: Latin America Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 66: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 67: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 68: Middle East & Africa Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 69: Middle East & Africa Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 70: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 71: Middle East & Africa Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 72: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 73: Middle East & Africa Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 74: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 75: Cartilage Degeneration Market Share Analysis of Companies, (Estimation)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Cartilage Degeneration Market